PD-1 agonist antibodies and uses thereof
US10493148B2 · kind B2 · utility
10Cited by
4References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 22, 2019 |
| Grant date | Dec 3, 2019 |
| Priority date | — |
| Expiry date | Feb 22, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to anti-human PD-1 agonist antibodies, and uses thereof for treating autoimmune disorders such as rheumatoid arthritis or for decreasing rejection of transplanted cells and/or tissues.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.